LTR Pharma and Aptar Pharma have entered into a co-development agreement for Spontan The primary goal is commercialisation of Spontan in the USA and other key global markets The agreement will ...

FMXIN002, also known as NS002, is a powder formulation of epinephrine nasal spray developed by Nasus Pharma ... FMXIN002 uses APTAR Nasal Unidose Powder device – an intuitive and easy-to-use ...